Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issues
This issue
18-4
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
18-4
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Journals
Journal #1024
advertisement
Current Neuropharmacology
20
Showing records 1 to 20 |
Display all abstracts in
Current Neuropharmacology
73411
Citicoline and Retinal Ganglion Cells: Effects on Morphology and Function
Parisi V
Current Neuropharmacology
2017; 0:
73542
Neuroprotection by (endo)cannabinoids in glaucoma and retinal neurodegenerative diseases
Rapino C
Current Neuropharmacology
2017; 0:
73416
Strategies to reduce oxidative stress in glaucoma patients
Pinazo-Durán MD
Current Neuropharmacology
2017; 0:
73522
Modulation of the immune system for the treatment of glaucoma
Bell K
Current Neuropharmacology
2017; 0:
73483
Genetic risk factors for glaucoma and exfoliation syndrome identified by genome-wide association studies
Sakurada Y; Mabuchi F
Current Neuropharmacology
2017; 0:
73542
Neuroprotection by (endo)cannabinoids in glaucoma and retinal neurodegenerative diseases
Tortolani D
Current Neuropharmacology
2017; 0:
73416
Strategies to reduce oxidative stress in glaucoma patients
Shoaie-Nia K
Current Neuropharmacology
2017; 0:
73411
Citicoline and Retinal Ganglion Cells: Effects on Morphology and Function
Oddone F
Current Neuropharmacology
2017; 0:
73522
Modulation of the immune system for the treatment of glaucoma
Und Hohenstein-Blaul NVT; Teister J
Current Neuropharmacology
2017; 0:
73411
Citicoline and Retinal Ganglion Cells: Effects on Morphology and Function
Ziccardi L
Current Neuropharmacology
2017; 0:
73542
Neuroprotection by (endo)cannabinoids in glaucoma and retinal neurodegenerative diseases
Scipioni L
Current Neuropharmacology
2017; 0:
73416
Strategies to reduce oxidative stress in glaucoma patients
Zanón-Moreno V
Current Neuropharmacology
2017; 0:
73542
Neuroprotection by (endo)cannabinoids in glaucoma and retinal neurodegenerative diseases
Maccarrone M
Current Neuropharmacology
2017; 0:
73411
Citicoline and Retinal Ganglion Cells: Effects on Morphology and Function
Roberti G
Current Neuropharmacology
2017; 0:
73522
Modulation of the immune system for the treatment of glaucoma
Grus FH
Current Neuropharmacology
2017; 0:
73416
Strategies to reduce oxidative stress in glaucoma patients
Sanz-González SM
Current Neuropharmacology
2017; 0:
73411
Citicoline and Retinal Ganglion Cells: Effects on Morphology and Function
Coppola G
Current Neuropharmacology
2017; 0:
73416
Strategies to reduce oxidative stress in glaucoma patients
Del Castillo J B
Current Neuropharmacology
2017; 0:
73411
Citicoline and Retinal Ganglion Cells: Effects on Morphology and Function
Manni G
Current Neuropharmacology
2017; 0:
73416
Strategies to reduce oxidative stress in glaucoma patients
García-Medina JJ
Current Neuropharmacology
2017; 0:
Issue
18-4
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept